F. HOFFMANN LA ROCHE LTD

F. Hoffmann-La Roche Ltd in Turkey operates as the local subsidiary of the global Roche Group, a leading pioneer in pharmaceuticals and diagnostics. The company's presence in Turkey is dedicated to bringing innovative healthcare solutions and advanced medical technologies to Turkish patients and the healthcare system.

Roche Turkey focuses on the commercialization, distribution, and marketing of a broad portfolio of pharmaceutical products across various therapeutic areas, including oncology, immunology, neuroscience, ophthalmology, and rare diseases. Additionally, it provides state-of-the-art diagnostic solutions, such as in-vitro diagnostics and tissue diagnostics, which are vital for disease detection, monitoring, and personalized treatment strategies. The Turkish entity is also actively involved in clinical trials and research, contributing to global scientific advancements and ensuring local patient access to cutting-edge therapies. Roche Turkey emphasizes collaboration with healthcare professionals, patient advocacy groups, and governmental bodies to improve health outcomes and enhance the overall quality of healthcare in the country.

Regarding whether it is a factory or a trading company:

F. Hoffmann-La Roche Ltd in Turkey functions primarily as a sales, marketing, and distribution company. It acts as a trading entity, responsible for importing finished pharmaceutical and diagnostic products from Roche's global manufacturing sites and distributing them within the Turkish market. It is not a primary manufacturing factory for the production of active pharmaceutical ingredients or large-scale drug formulation in Turkey. Its core activities revolve around making Roche's global innovations available and accessible to patients and healthcare providers in Turkey.

F. Hoffmann-La Roche Ltd in Turkey, operating as Roche Turkey, sells and distributes a comprehensive portfolio of pharmaceutical products and diagnostic solutions.

Key pharmaceutical products and therapeutic areas include:

Oncology: Products such as Herceptin trastuzumab, Avastin bevacizumab, Rituxan MabThera rituximab, Tecentriq atezolizumab, Perjeta pertuzumab, Kadcyla trastuzumab emtansine, and Alecensa alectinib are available for various cancer types.

Immunology: Actemra RoActemra tocilizumab for rheumatoid arthritis and other inflammatory conditions, and Esbriet pirfenidone for idiopathic pulmonary fibrosis.

Neuroscience: Ocrevus ocrelizumab for multiple sclerosis.

Ophthalmology: Vabysmo faricimab for retinal diseases.

Hematology: Hemlibra emicizumab for hemophilia A.

Rare Diseases: Evrysdi risdiplam for spinal muscular atrophy.

In the field of Diagnostics, Roche Turkey offers a wide range of solutions including:

Clinical Chemistry and Immunodiagnostics: Analyzers and reagents for general health screening, cardiac markers, infectious diseases, and more.

Molecular Diagnostics: Systems and tests for PCR, virology, microbiology, and genomics applications.

Tissue Diagnostics: Products for advanced staining and pathology workflows.

Point-of-Care Testing: Devices for rapid and convenient testing in various healthcare settings.

This list represents major categories and examples of the products available through Roche Turkey.